Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raynier Devillier

Showing results (21-30 of 111) with videos related to

Pageof 12
Sort By:
American Journal of Hematology|June 15, 2016
Epigenetically centered evolution in an example of myeloid malignancyJosé Adélaide, Nathalie Cervera, Nadine Carbuccia, et al.
Blood Advances|March 11, 2026
Effect of Deferasirox Six Months after allo-HSCT on AML/MDS Outcomes: a Propensity-Score Matched StudyRomain Buono, Anne Huynh, Edouard Forcade, et al.
Leukemia & Lymphoma|October 23, 2012
Outcome of relapse after allogeneic stem cell transplant in patients with acute myeloid leukemiaRaynier Devillier, Roberto Crocchiolo, Anne Etienne, et al.
Transfusion|October 19, 2019
A matched-pair analysis reveals marginally reduced CD34+ cell mobilization on second occasion in 27 related donors who underwent peripheral blood stem cell collection twice at the same institutionMelanie Velier, Angela Granata, Stefania Bramanti, et al.
British Journal of Haematology|June 11, 2015
Combination therapy with ruxolitinib plus intensive treatment strategy is feasible in patients with blast-phase myeloproliferative neoplasmsRaynier Devillier, Emmanuel Raffoux, Jérôme Rey, et al.
American Journal of Hematology|November 4, 2014
Comparison of 60 or 90 mg/m(2) of daunorubicin in induction therapy for acute myeloid leukemia with intermediate or unfavorable cytogeneticsRaynier Devillier, Sarah Bertoli, Thomas Prébet, et al.
Cancer|October 26, 2012
Two days of antithymocyte globulin are associated with a reduced incidence of acute and chronic graft-versus-host disease in reduced-intensity conditioning transplantation for hematologic diseasesRoberto Crocchiolo, Benjamin Esterni, Luca Castagna, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 14, 2017
Haploidentical Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Post-Transplantation Cyclophosphamide Graft-versus-Host Disease ProphylaxisLuca Castagna, Alberto Mussetti, Raynier Devillier, et al.
Haematologica|September 3, 2013
Array comparative genomic hybridization and sequencing of 23 genes in 80 patients with myelofibrosis at chronic or acute phaseMandy Brecqueville, Jérôme Rey, Raynier Devillier, et al.
Haematologica|January 25, 2012
Positron emission tomography response at the time of autologous stem cell transplantation predicts outcome of patients with relapsed and/or refractory Hodgkin's lymphoma responding to prior salvage therapyRaynier Devillier, Diane Coso, Luca Castagna, et al.
Pageof 12

Showing results (21-30 of 111) with videos related to

Sort By:
Pageof 12
American Journal of Hematology|June 15, 2016
Epigenetically centered evolution in an example of myeloid malignancyJosé Adélaide, Nathalie Cervera, Nadine Carbuccia, et al.
Blood Advances|March 11, 2026
Effect of Deferasirox Six Months after allo-HSCT on AML/MDS Outcomes: a Propensity-Score Matched StudyRomain Buono, Anne Huynh, Edouard Forcade, et al.
Leukemia & Lymphoma|October 23, 2012
Outcome of relapse after allogeneic stem cell transplant in patients with acute myeloid leukemiaRaynier Devillier, Roberto Crocchiolo, Anne Etienne, et al.
Transfusion|October 19, 2019
A matched-pair analysis reveals marginally reduced CD34+ cell mobilization on second occasion in 27 related donors who underwent peripheral blood stem cell collection twice at the same institutionMelanie Velier, Angela Granata, Stefania Bramanti, et al.
British Journal of Haematology|June 11, 2015
Combination therapy with ruxolitinib plus intensive treatment strategy is feasible in patients with blast-phase myeloproliferative neoplasmsRaynier Devillier, Emmanuel Raffoux, Jérôme Rey, et al.
American Journal of Hematology|November 4, 2014
Comparison of 60 or 90 mg/m(2) of daunorubicin in induction therapy for acute myeloid leukemia with intermediate or unfavorable cytogeneticsRaynier Devillier, Sarah Bertoli, Thomas Prébet, et al.
Cancer|October 26, 2012
Two days of antithymocyte globulin are associated with a reduced incidence of acute and chronic graft-versus-host disease in reduced-intensity conditioning transplantation for hematologic diseasesRoberto Crocchiolo, Benjamin Esterni, Luca Castagna, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 14, 2017
Haploidentical Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Post-Transplantation Cyclophosphamide Graft-versus-Host Disease ProphylaxisLuca Castagna, Alberto Mussetti, Raynier Devillier, et al.
Haematologica|September 3, 2013
Array comparative genomic hybridization and sequencing of 23 genes in 80 patients with myelofibrosis at chronic or acute phaseMandy Brecqueville, Jérôme Rey, Raynier Devillier, et al.
Haematologica|January 25, 2012
Positron emission tomography response at the time of autologous stem cell transplantation predicts outcome of patients with relapsed and/or refractory Hodgkin's lymphoma responding to prior salvage therapyRaynier Devillier, Diane Coso, Luca Castagna, et al.
Pageof 12